首页> 外国专利> RECOMBINANT VACCINIA VIRUS HAVING HEMAGGLUTININ PROTEIN GENES DERIVED FROM NOVEL INFLUENZA VIRUSES

RECOMBINANT VACCINIA VIRUS HAVING HEMAGGLUTININ PROTEIN GENES DERIVED FROM NOVEL INFLUENZA VIRUSES

机译:具有源自新型流感病毒的血凝素蛋白基因的重组痘苗病毒

摘要

The present invention provides a recombinant vaccinia virus which is effective in preventing the infection caused by a new influenza virus infection and has high safety, and a vaccine for a new influenza virus including the same. The recombinant Vaccinia virus according to the present invention can express the hemagglutinin protein gene of the new influenza virus. The novel influenza virus vaccine according to the present invention comprises the recombinant vaccinia virus.
机译:本发明提供了对预防由新型流感病毒感染引起的感染有效并且具有高安全性的重组痘苗病毒,以及包括该疫苗的新型流感病毒疫苗。根据本发明的重组痘苗病毒可以表达新流感病毒的血凝素蛋白基因。根据本发明的新型流感病毒疫苗包含重组牛痘病毒。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号